Literature DB >> 8786972

Effect of acute renal failure on neurotoxicity of cimetidine in rats.

Y Nakada1, K Yamamoto, J Kawakami, Y Sawada, T Iga.   

Abstract

PURPOSE: We investigated the effect of acute renal failure on the neurotoxicity of cimetidine in rats.
METHODS: Experimental acute renal failure was produced by bilateral ureteral ligation. Cimetidine was intravenously infused to ureter ligated (UL) and control rats, and cimetidine concentration in plasma, brain and cerebrospinal fluid (CSF) were compared.
RESULTS: The cimetidine concentration in plasma was rapidly increased in UL rats as compared to control rats. The cimetidine concentration in CSF at the onset of convulsion did not depend on the infusion rate, suggesting that cimetidine in CSF equilibrates rapidly with the site of action for clonic convulsion. The cimetidine concentration in CSF of UL rats at the onset of clonic convulsion was lower than those of control rats.
CONCLUSIONS: Increased sensitivity to the drug on the central nervous system may contribute to increased toxicity of cimetidine with renal failure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8786972     DOI: 10.1023/a:1016200208174

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Kinetics of drug action in disease states. XIII. Effect of dialyzable component(s) of uremic blood on phenobarbital concentrations in rats at onset of loss of righting reflex.

Authors:  M Hisaoka; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1985-07       Impact factor: 4.030

2.  Cimetidine: does neurotoxicity occur? Report of three cases.

Authors:  M E Edmonds; R F Ashford; M K Brenner; A Saunders
Journal:  J R Soc Med       Date:  1979-03       Impact factor: 5.344

3.  Effect of renal or hepatic dysfunction on neurotoxic convulsion induced by ranitidine in mice.

Authors:  M Shimokawa; K Yamamoto; J Kawakami; Y Sawada; T Iga
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

4.  Kinetics of drug action in disease states. I. Effect of infusion rate on phenobarbital concentrations in serum, brain and cerebrospinal fluid of normal rats at onset of loss of righting reflex.

Authors:  M Danhof; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1984-04       Impact factor: 4.030

5.  Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure.

Authors:  A Hoffman; G Levy
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

6.  Cimetidine-associated mental confusion: further studies in 36 severely ill patients.

Authors:  J J Schentag
Journal:  Ther Drug Monit       Date:  1980       Impact factor: 3.681

7.  Dose and serum concentration relationships in cimetidine-associated mental confusion.

Authors:  B J Kimelblatt; F B Cerra; G Calleri; M J Berg; M A McMillen; J J Schentag
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

8.  Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion.

Authors:  J J Schentag; F B Cerra; G Calleri; E DeGlopper; J Q Rose; H Bernhard
Journal:  Lancet       Date:  1979-01-27       Impact factor: 79.321

9.  Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats.

Authors:  I M Ramzan; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1986-03       Impact factor: 4.030

10.  Kinetics of drug action in disease states. II. Effect of experimental renal dysfunction on phenobarbital concentrations in rats at onset of loss of righting reflect.

Authors:  M Danhof; M Hisaoka; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1984-09       Impact factor: 4.030

View more
  2 in total

1.  Effect of experimental renal failure and hypotonic hyponatremia on the pharmacodynamics of cefazolin-induced seizures in rats.

Authors:  Masashi Nagata; Takuya Fujichika; Masato Yasuhara
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

Review 2.  Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.

Authors:  G R Matzke; R F Frye
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.